There is a critical need to non-invasively and remotely manipulate cells at a distance, particularly for translational applications in animals and humans, researchers said.
They developed an innovative approach to use mechanogenetics - a field of science that focuses on how physical forces and changes in the mechanical properties of cells and tissues influence gene expression - for the remote control of gene and cell activations.
The team from University of California, San Diego in the US used ultrasound to mechanically perturb T cells, and then converted the mechanical signals into genetic control of cells.
The engineered CAR-T cells have mechano-sensors and genetic transducing modules that can be remotely activated by ultrasound via microbubble amplification.
More From This Section
"CAR-T cell therapy is becoming a paradigm-shifting therapeutic approach for cancer treatment," said Peter Yingxiao Wang, professor at the UC San Diego.
"However, major challenges remain before CAR-based immunotherapy can become widely adopted. For instance, the non-specific targeting of CAR-T cells against nonmalignant tissues can be life-threatening," said Wang.
"This work could ultimately lead to an unprecedented precision and efficiency in CAR-T cell immunotherapy against solid tumors, while minimizing off-tumor toxicities," said Wang.
Upon exposure to ultrasound waves, microbubbles vibrate and mechanically stimulate Piezo1 ion channels to let calcium ions inside the cell.
This triggers downstream pathways, including calcineurin activation, NFAT dephoshorylation and translocation into the nucleus.
The nucleus-translocated NFAT can bind to upstream response elements of genetic transducing modules to initiate gene expression of chimeric antigen receptor (CAR) for the recognition and killing of target cancer cells.